Adamantiades-Behçet's disease;Morbus Adamantiades-Behçet

Ophthalmologe

Volumn 102, Issue 4, 2005, Pages 329-334

  Krause, L ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adamantiades Beh et's disease; Uveitis; Vasculitis

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; CHLORAMBUCIL; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADAMANTIADES BEHCET DISEASE; ARTHRITIS; BONE MARROW TOXICITY; CATARACT; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA NODOSUM; GENITAL ULCER; GLAUCOMA; HUMAN; IRIDOCYCLITIS; NEUROPATHY; RECURRENT DISEASE; RETINA DETACHMENT; RETINA MACULA EDEMA; RETINA VASCULITIS; REVIEW; SIDE EFFECT; SKIN DISEASE; SUPERFICIAL THROMBOPHLEBITIS; UVEITIS; VASCULITIS;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; BEHCET SYNDROME; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; PANUVEITIS; RECEPTORS, TUMOR NECROSIS FACTOR; RETINAL VASCULITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 17744379976     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-004-1166-2     Document Type: Review

References (35)

1. Adamantiades B (1931) Sur un cas d íritis hypopyon recidivant. Ann Oculist 168:271-278
2. Adler YD, Jovanovic S, Jivanjee A, Krause L, Zouboulis CC (2002) Adamantiades-Behcet's disease with inner ear involvement. Clin Exp Rheumatol 20 [4 Suppl 26]:S40-42
3. Alpsoy E, Yilmaz E, Basaran E (1994) Interferon therapy for Behcet's disease. J Am Acad Dermatol 31 (4):617-619
4. Azizlerli G, Kose AA, Sarica R et al. (2003) Prevalence of Behcet's disease in Istanbul, Turkey. Int J Dermatol 42 (10):803-806
5. Bang D (1997) Treatment of Behcet's disease. Yonsei Med J 38 (6):401-410
6. Bang DS, Oh SH, Lee KH, Lee ES, Lee SN (2003) Influence of sex on patients with Behcet's disease in Korea. J Korean Med Sci 18 (2):231-235
7. Barnes CG, Yazici H (1999) Behcet's syndrome. Rheumatology (Oxford) 38 (12):1171-1174
8. Behçet H (1937) Über rezidivierende, aphtöse, durch ein Virus verursachte Geschwüre im Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105:1152-1157
9. Davies PG, Fordham JN, Kirwan JR, Barnes CG, Dinning WJ (1984) The pathergy test and Behcet's syndrome in Britain. Ann Rheum Dis 43 (1):70-73
10. Hamuryudan V, Ozyazgan Y, Hizli N et al. (1997) Azathioprine in Behcet's syndrome: effects on long-term prognosis. Arthritis Rheum 40 (4):769-774
11. Hamuryudan V, Ozyazgan Y, Fresko Y, Mat C, Yurdakul S, Yazici H (2002) Interferon alfa combined with azathioprine for the uveitis of Behcet's disease: an open study. Isr Med Assoc J 4 [Suppl 11]:928-930
12. International Study Group for Behcet's Disease (1990) Criteria for diagnosis of Behcet's disease. Lancet 335 (8697):1078-1080
13. Kotter I, Zierhut M, Eckstein AK et al. (2003) Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol 87 (4):423-431
14. Krause L (2004) Morbus Adamantiades-Behçet. In: Heimann H, Kellner U, Foerster MH (Hrsg) Angiographie-Atlas des Augenhintergrundes. Thieme, Stuttgart New York, S 126-127
15. Krause L, Hoffmann F, Zouboulis CC, Foerster MH (2003) Vitrectomy and trabeculectomy combined with interferon alpha treatment in Adamantiades-Behcet's disease: a case report. Graefes Arch Clin Exp Ophthalmol 241 (10):871-874
16. Krause L, Turnbull JR, Torun N, Pleyer U, Zouboulis CC, Foerster MH (2003) Interferon alfa-2a in the treatment of ocular Adamantiades-Behcet's disease. Adv Exp Med Biol 528:511-519
17. Masuda K (1975) A nation-wide survey of Behçet's disease in Japan. Jpn J Ophthalmol 19:278-285
18. Ozerturk Y, Bardak Y, Durmus M (2001) Vitreoretinal surgery in Behcet's disease with severe ocular complications. Acta Ophthalmol Scand 79 (2):192-196
19. Saenz A, Ausejo M, Shea B, Wells G, Welch V, Tugwell P (2002) Pharmacotherapy for Behcet's syndrome. Cochrane Database Syst Rev 2000 (2): CD001084
20. Sakane T, Takeno M (2000) Current therapy in Behcet's disease. Skin Therapy Lett 5 (6):3-5
21. Sfikakis PP, Kaklamanis PH, Elezoglou A et al. (2004) Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behcet disease. Ann Intern Med 140 (5):404-406
22. Shahram F, Davatchi F, Nadji A et al. (2003) Recent epidemiological data on Behcet's disease in Iran. The 2001 survey. Adv Exp Med Biol 528:31-36
23. Soylu M, Demircan N, Pelit A (2001) Pars plana vitrectomy in ocular Behcet's disease. Int Ophthalmol 24 (4):219-223
24. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M (2004) Uveitis in Behcet disease: an analysis of 880 patients. Am J Ophthalmol 138 (3):373-380
25. Wechsler B, Bodaghi B, Huong DL et al. (2000) Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behcet's disease. Ocul Immunol Inflamm 8 (4):293-301
26. Yazici H, Barnes CG (1991) Practical treatment recommendations for pharmacotherapy of Behcet's syndrome. Drugs 42 (5):796-804
27. Yazici H, Ozyazgan Y (1999) Medical management of Behcet's syndrome. Dev Ophthalmol 31:118-131
28. Yazici H, Pazarli H, Barnes CG et al. (1990) A controlled trial of azathioprine in Behcet's syndrome. N Engl J Med 322 (5):281-285
29. Yurdakul S, Hamuryudan V, Yazici H (2004) Behcet syndrome. Curr Opin Rheumatol 16(1):38-42
30. Zouboulis CC (1999) Epidemiology of Adamantiades-Behcet's disease. Ann Med Interne (Paris) 150 (6):488-498
31. Zouboulis CC, Keitel W (2003) A historical review of Adamantiades- Behcet's disease. Adv Exp Med Biol 528:7-14
32. Zouboulis CC, May T (2003) Pathogenesis of Adamantiades-Behcet's disease. Adv Exp Med Biol 528:161-171
33. Zouboulis CC, Orfanos CE (1998) Treatment of Adamantiades-Behcet disease with systemic interferon alfa. Arch Dermatol 134 (8):1010-1016
34. Zouboulis CC, Kotter I, Djawari D et al. (2003) Current epidemiological data from the German Registry of Adamantiades-Behcet's disease. Adv Exp Med Biol 528:43-48
35. Zouboulis CC, Turnbull JR, Muhlradt PF (2003) High seroprevalence of anti-Mycoplasma fermentans antibodies in patients with malignant aphthosis. J Invest Dermatol 121 (1):211-212